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Abstract
Aims: A pilot randomized controlled trial (RCT) to assess the feasibility and potential efﬁcacy of
assertive community treatment (ACT) in adults with alcohol dependence.
Methods: Single blind, individually randomized, pilot RCT of 12 months of ACT plus treatment as
usual (TAU) versus TAU alone in adults (age 18+ years) with alcohol dependence and a history of pre-
vious unsuccessful alcohol treatment attending specialist community alcohol treatment services.
ACT aimed to actively engage participants for 12 months with assertive, regular, minimum weekly
contact. ACT was combined with TAU. TAU comprised access to the full range of services provided
by the community teams. Primary outcome is mean drinks per drinking day and percent days abstin-
ent at 12 months follow up. Analysis of covariance was conducted using 80% conﬁdence intervals,
appropriate in the context of a pilot trial.
Results: A total of 94 participants were randomized, 45 in ACT and 49 in TAU. Follow-up was
achieved with 98 and 88%, respectively at 12 months. Those in ACT had better treatment engage-
ment, and were more often seen in their homes or local community than TAU participants. At
12 months the ACT group had more problems related to drinking and lower quality of life than TAU
but no differences in drinking measures. The ACT group had a higher percentage of days abstinent
but lower quality of life at 6 months. The ACT group had less unplanned healthcare use than TAU.
Conclusions: An trial of ACT was feasible to implement in an alcohol dependent treatment population.
Trial registration: ISRCTN22775534
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INTRODUCTION
Excessive alcohol use places a considerable burden on society, and is
the ﬁfth leading cause of disability globally (Lim et al., 2012). In
England, ~4% of the adult population are alcohol dependent
(McManus et al., 2009) and the government has identiﬁed provision
of effective treatment as a priority in reducing these costs (HM
Government, 2012). Current specialist alcohol service provision in
the UK focuses on discrete, time-limited episodes of intervention,
typically up to 12 weeks duration and emphasizes personal choice
and motivation. However, there are high rates of non-attendance in
the treatment population (Mitchell and Selmes, 2007), <40% com-
plete a treatment programme (Passetti et al., 2008), and after suc-
cessful completion approximately one-third continue to drink
heavily and have poor long-term outcomes (Marshall et al., 1994).
For this group of patients alcohol dependence is a chronic relapsing
disorder and in typical practice, treatment episodes extending over
many years is typical. Current alcohol care pathways require signiﬁ-
cant levels of motivation and self-efﬁcacy to navigate, that few
patients possess (Gilburt et al., 2015).
Assertive community treatment (ACT) is a model of intensive
case management which has been shown to be effective in improving
engagement and retaining those with serious mental illness and
those with alcohol and drug use comorbidities (Dieterich et al.,
2010). A number of studies have applied individual components of
ACT to the treatment of alcohol dependence with positive outcomes
(Gilbert, 1998; Stout et al., 1999; Hilton et al., 2001). A non-
randomized cohort study of assertive engagement methods resulted
in a signiﬁcantly greater number of patients completing treatment
and entering aftercare (Passetti et al., 2008). However, the potential
beneﬁts of individual elements of ACT in patients with alcohol
dependence without severe mental illness remain unclear, and there
have been no published randomized controlled trials investigating
the impact of ACT in this population to date. We therefore con-
ducted a pilot randomized controlled trial of ACT in people with
alcohol dependence and a history of previous unsuccessful treatment
to investigate (a) the feasibility of recruiting and retaining people
seeking treatment for alcohol dependence in a clinical trial of ACT
and (b) the potential efﬁcacy of ACT on the drinking behaviours
and quality of life of people with alcohol dependence and a history
of disengagement from specialist alcohol treatment services.
METHOD
This study (ACTAD trial) was reviewed and approved by the National
Research Ethics Service Committee London—Chelsea (REC number:
08/H0801/113) and the trial was registered with the International
Standard Randomized Controlled Trial registry (ISRCTN22775534)
prior to the commencement of data collection. Progress of the trial,
adherence to protocol and participant safety were overseen by an inde-
pendent trial steering committee. A detailed protocol for the study has
already been published (Gilburt et al., 2012).
Trial design
We undertook a single blind, pilot randomized controlled trial of
ACT plus treatment as usual (TAU) compared with a TAU alone for
people with alcohol dependence. The trial was conducted across two
NHS trusts in South London: participants were recruited at the
point of referral to one of three specialist community drug and alco-
hol services for a new episode of treatment. Participants were
recruited between 23 March 2010 and 23 January 2012.
An equal number was randomized to each treatment condition.
Randomization was conducted using a secure independent service at
the level of the individual and was stratiﬁed by alcohol dependence
(≤30 and >30) as measured by the Severity of Alcohol Dependence
Questionnaire (Stockwell et al., 1979) and by site.
As a pilot study, the sample size was selected to determine feasi-
bility and to allow for an analysis of potential effect prior to design-
ing a full scale deﬁnitive trial. In order to ascertain these parameters,
we considered a clinically meaningful difference in alcohol consump-
tion between the groups at 12 months to be of the order of 30%
and estimated the numbers required with 80% power and an alpha
of 0.2, appropriate for a pilot study, using two-sided test. In add-
ition, we considered an acceptable rate of follow-up at 12 months to
be not less than 75%. Our required sample size was estimated as 45
in each group at baseline, with the expectation that at least 34
would be followed-up at 12 months.
Recruitment
All potential participants were in the ﬁrst instance identiﬁed and
approached by a member of the community drug and alcohol team
who informed them about the trial and obtained verbal consent to
being contacted by a researcher. A member of the research team met
with the participant to explain the trial further and check eligibility
for the trial. Participants who met all the criteria were invited to
provide written consent for the trial.
Inclusion and exclusion criteria
All participants met the following criteria: (a) age 18 years or over;
(b) able to understand English sufﬁciently well to obtain informed
consent and complete the assessment instruments; (c) attended an
NHS community addiction service in either of the participating
trusts for alcohol dependence on at least one previous occasion in
the last 5 years; and (d) an ICD-10 diagnosis of alcohol dependence
as determined using the Composite International Diagnostic
Interview (Robins et al., 1988). We excluded patients who were:
(a) unable to provide written informed consent; (b) street homeless;
(c) diagnosed with a psychotic disorder; (d) in receipt of assertive
outreach services or had community mental health team input once
a month or more; (e) had severe cognitive impairment as determined
by the Mini Mental State Examination score of ≤10 (Folstein et al.,
1975); and (f) who had a history of violence to staff or were regis-
tered under the UK Multi-Agency Public Protection Arrangement.
Interventions
Assertive community treatment
The intervention was informed by the original ACT model used for
people with psychosis and ﬁndings from research identifying effect-
ive elements of assertive outreach in UK studies (Burns et al., 2000).
The ACT intervention comprised:
(i) A maximum caseload of 15 ACT patients per ACT
practitioner.
(ii) Input from a multidisciplinary team (including psychiatrists
and substance misuse specialists).
(iii) Regular contact (minimum of once a week), with 50% of con-
tacts occurring outside of the service settings either in the
patients’ home or neighbourhood, and in which short frequent
contacts rather than long complex contacts were encouraged.
(iv) Assertive engagement where there were persistent and
repeated attempts to contact, and an emphasis on maintaining
contact and building relationships.
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(v) A focus on both health and social care needs, including
accommodation, leisure, occupation and physical and mental
health.
(vi) A ﬂexible approach, focusing on the patient’s goals even when
these were peripheral to the alcohol dependence.
(vii) Practitioners were explicit about their role both in care plan-
ning and in visits.
(viii) An ethos of ‘going out of your way’, where practitioners are
encouraged to step outside of professional roles and ‘go the
extra mile’ for patients.
(ix) Extended care provided for a prolonged period of 1 year.
An intervention manual was developed in collaboration with
experts in the provision of ACT. The manual outlined the core com-
ponents of the ACT intervention and the principles of delivery in
line with components of the alcohol treatment pathway. This
included hours of operation, caseload, target client group, source of
referrals, assessment, interventions and care plan and the use of
interventions for alcohol dependence. Policies on training and devel-
opment for ACT practitioners, home visiting, lone working and risk
assessment and the withdrawal from treatment were also incorpo-
rated. Finally the manual provided an overview of the research pro-
cesses involved in the trial.
Treatment as usual
Participants randomized to the intervention arm received TAU plus
ACT, while those randomized to the control group received TAU
alone. TAU included the allocation of a keyworker when available
with contact as required as per local team policies. Contact was pri-
marily conducted within a service setting (community addictions ser-
vice or general practice) via an appointment-based system. These
NHS services specialize in treatment of patients with drug and/or
alcohol dependence. They are located in community-based treatment
centres and staffed by multidisciplinary teams comprising specialist
addiction psychiatrists, nurses, clinical psychologists, social workers,
counsellors and community support workers. They provide a wide
range of interventions in accordance with national clinical guidelines
(Department of Health, 2007; National Institute for Health and
Care Excellence, 2011). Participants received a full assessment of
alcohol, social and physical health needs and a risk assessment. The
focus of treatment was primarily on alcohol dependence, promoting
abstinence and relapse prevention. This included access to medical
detoxiﬁcation, psychological interventions focused on drinking
behaviour and aftercare as required. TAU also included input from
specialists in addiction psychiatry, clinical psychology and social
work where available. When these services were not directly pro-
vided by the community drug and alcohol treatment service, partici-
pants were most often referred or signposted to other relevant
agencies as required. The majority of participants were discharged
to primary care from the specialist service within 12 weeks of being
allocated a keyworker unless signiﬁcant risks were identiﬁed. Failure
to attend several appointments resulted in discharge from the ser-
vice. These approaches are broadly in line with national service
delivery at the time of the study. In addition we collected data on
the actual care received in order to understand the content of TAU.
Training and support
A training programme for ACT staff was developed by the team in
collaboration with experts in ACT and addictions treatment. The
training comprised workshops providing information on ACT, its
history, implementation in mental health and trial processes; a 1-day
clinical placement with a mental health assertive outreach team sha-
dowing a member of staff; and a ﬁnal workshop day focused on the
application of ACT in addictions services. A total of seven practi-
tioners from the trial sites attended the training (four from one ser-
vice, three from the second) including substance misuse, nursing and
addiction psychiatry professionals. Additional training was delivered
on a one-to-one basis to a further three practitioners at a third ser-
vice setting following late incorporation into the trial, and in
response to staff turnover.
In addition to existing team-based clinical supervision, practi-
tioners delivering ACT were encouraged to attend monthly ACT
group supervision meetings throughout the course of the study.
These meetings were facilitated by the Chief Investigator, an experi-
enced addictions psychiatrist, and the trial manager. Meetings
focused on enabling practitioners to share experience and practice in
order to support delivery of ACT, address clinical issues arising as a
result of the intervention, and reinforce ﬁdelity of the ACT
intervention.
Intervention ﬁdelity
Staff providing care to participants in both arms of the trial com-
pleted a contact log detailing the care they provided for each patient
following each contact. The log, developed from a previous study of
assertive outreach, included details about the mode of contact, (i.e.
face to face, telephone), setting, focus of contact, and the member of
staff involved (Burns et al., 2000). To enhance accuracy, data were
additionally collected from the electronic clinical records of each
participating service following completion of the trial. Data high-
lighting additional contacts with a participant and information
absent from contacts recorded in the log was used to supplement
existing information.
Outcome measures
Feasibility and acceptability of delivering ACT to people with alco-
hol dependence was measured by levels of recruitment into the trial
and retention of participants in both arms of the study at 12 months
follow-up.
The primary outcome measures were mean drinks per drinking
day and percent days abstinent at 12 months measured using the
Time Line Follow Back form 90 (TLFB; Miller, 1995). Secondary
outcomes included total alcohol consumed, other consumption mea-
sures at 6 months and other drug use measured using TLFB,
alcohol-related problems (Alcohol Problems Questionnaire; APQ;
Drummond, 1990), severity of alcohol dependence (Severity of
Alcohol Dependence Questionnaire; SADQ; Stockwell et al., 1979),
health utility (EQ-5D; EuroQol Group, 1990), health-related quality
of life (SF-12; Ware et al., 1996), motivation to change (Readiness
to Change Treatment version; Heather et al., 1999), social network
involvement (Important People and Activities Inventory; Zywiak
et al., 2002), health service utilization (York Service Use
Questionnaire; Drummond et al., 2009). All measured at baseline
and then 6 and 12 months after randomization. Data were collected
through face-to-face interviews conducted by trained researchers
working on this trial who were blinded to the treatment allocation.
All participants were reminded by the researcher at the beginning of
each follow-up interview not to reveal the treatment allocation they
received. For each time point (including the baseline) assessment
was made was of the previous 6 months. However, in the case of
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TLFB form 90 for alcohol and drugs the time period covered at each
time point was the previous 90 days.
Statistical analysis
The main hypothesis, stated as a null hypothesis, is that TAU augmen-
ted with ACT is no more effective than TAU in reducing alcohol con-
sumption 12 months after randomization. The primary outcome
measure was mean drinks per drinking day and percent days abstinent
at 12 months follow up. Our primary analysis was by intention-to-
treat in which participants are analysed as part of their allocated group
irrespective of the treatment received. This provides the most rigorous
estimate of effectiveness. The primary outcome measure was analysed
using an analysis of covariance approach adjusting for known con-
founding variables such as baseline mean drinks per drinking day, age
and gender. If the assumptions underlying ANCOVA were not met
transformations were undertaken and if transformations were not
viable alternative non-parametric approaches were used. Continuous
secondary measures were analysed in a similar manner. Categorical
variables were analysed using chi-squared statistics and binary out-
comes analysed using logistic regression controlling for known con-
founding variables. Estimates and the 80% conﬁdence intervals are
presented.
RESULTS
Feasibility of recruitment
Feasibility outcomes for this study were assessed by recruitment and
retention rates in both arms of the study. Participant ﬂow is indi-
cated in the Consort diagram (Fig. 1). Of 126 individuals assessed
for eligibility, four could not be contacted after referral by the team,
Enrollment
Approached (n = 126)
Not assessed (n = 9; 7.0%)
Not contactable n = 4
Declined to participate n = 2
Too intoxicated to participate n = 2
Needed urgent treatment n = 1
Assessed for eligibility (n = 117; 93.0% of approached)
Excluded (n = 23; 19.7% of assessed)
Treatment last 3 months n = 7
Diagnosis of psychosis n = 5
No previous treatment n = 5
No treatment last 5 yrs n = 3
Not alcohol dependent n = 2
History of violence n = 1
Randomised (n = 94; 80.3% of assessed)
Randomised to TAU (n = 49; 52.1%)Randomised to ACT+TAU (n = 45; 47.9%)
Followed up 6 months (n = 45; 100%) Followed up 6months (n = 42; 86%)
Followed up 12 months (n = 44; 98%) Followed up 12 months (n = 43; 88%)
Randomisation
Fig. 1. Trial consort diagram.
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two declined to participate, two were assessed as too intoxicated to
participate and one needed to be seen immediately by the clinical
team so could not be seen by a researcher. A total of 117 (93.0%)
patients were assessed for eligibility to take part. Of all, 23 did not
meet the inclusion criteria (seven had been seen for treatment in the
last 3 months, ﬁve had been diagnosed with a psychotic disorder,
ﬁve had no history of treatment with the service, three had not been
seen by the service within the last 5 years, two were not alcohol
dependent and one had a signiﬁcant history of violence).
A total of 94 (80.3%) provided consent and were randomized.
Overall, 45 participants were randomized to ACT plus TAU arm
(47.9%) and 49 participants were randomized to the TAU arm
(52.1%). The follow-up rates at 6 months were 100% (n = 45) in
the ACT plus TAU arm and 86% (n = 42) in the TAU arm. The
follow-up rates at 12 months were 98% (n = 44) in the ACT plus
TAU arm and 88% (n = 43) in the TAU arm.
Baseline characteristics
The baseline demographics of the sample are shown in Table 1. The
majority of the sample was male (61%), white (87%), not currently
in a marital relationship (68%), and living in rented or temporary
accommodation (76%), were parents (68%), and had a basic level
of educational qualiﬁcations (67%). The mean age was 43 years.
At baseline no signiﬁcant differences were observed between the
groups in terms of study outcome measures (Table 2). All partici-
pants met the criteria for alcohol dependence with lower than popu-
lation average mental and physical health-related quality of life. The
majority were in the pre-contemplative stage of change and had
high levels of alcohol dependence.
Intervention delivery
Compared with participants randomized to the TAU arm of the trial,
participants receiving ACT + TAU were in contact with services for a
signiﬁcantly longer period of time, (t(76.77) = 15.62, P < 0.001),
received a greater mean number of contacts during treatment
(t(57.75) = 10.52, P < 0.001), and received a signiﬁcantly greater
percentage of contacts in a venue other than the addictions treatment
service (t(66.34) = 7.47, P < 0.001).
Primary outcomes
Tables 3 and 4 contain outcomes at 6 and 12 months. Data pre-
sented has been adjusted by baseline covariates; baseline value, age
and gender. There were reductions in the total alcohol consumed
and increases in the percent days abstinent and number of partici-
pants abstinent at 12 months. There were reductions in drinks per
drinking day in both groups at 12 months compared to baseline but
Table 1. Demographics of the sample
ACT + TAU
(n = 45)
TAU
(n = 49)
Overall
(n = 94)
Mean age (SD) 42.6 (9.6) 43.2 (9.3) 43.0 (9.6)
Male, n (%) 26 (58) 31 (63) 57 (61)
Ethnicity, n (%)
White 38 (84) 44 (90) 82 (87)
Black 2 (4) 1 (2) 3 (3)
Asian 3 (6) 2 (4) 5 (4)
Other 4 (2) 2 (4) 6 (6)
Marital status, n (%)
Never married 18 (40) 20 (41) 38 (40)
With partner 6 (13) 4 (8) 10 (11)
Married 10 (22) 10 (20) 20 (21)
Separated 6 (13) 5 (10) 11 (12)
Divorced 5 (12) 8 (16) 13 (14)
Widowed 0 2 (5) 2 (2)
Accommodation, n (%)
Owner/ occupier 11 (24) 12 (24) 23 (24)
Rented/ temporary 34 (76) 37 (76) 71 (76)
Educational qualiﬁcations, n (%)
None 17 (38) 14 (28) 31 (33)
GCSE or equivalent or higher 28 (62) 35 (86) 63 (67)
Children, n (%) 30 (67) 34 (69) 64 (68)
Table 2. Outcomes by allocated group at baseline, 6 and 12 months
Baseline Month 6 Month 12
ACT + TAU
(n = 45)
TAU
(n = 49)
ACT + TAU
(n = 43)
TAU
(n = 44)
ACT+TAU
(n = 42)
TAU
(n = 45)
Alcohol use in past 90 days
Mean drinksa consumed (SE) 2074 (232.9) 1926 (175.1) 722.8 (167.9) 816.3 (160.6) 728.9 (152.3) 774.1 (148.7)
Mean drinks per day (SE) 23.05 (2.6) 21.41 (1.9) 8.032 (1.9) 9.070 (1.8) 8.099 (1.7) 8.601 (1.6)
Mean percent days abstinent (SE) 13.80 (2.9) 14.24 (2.8) 67.83 (5.8) 57.40 (6.2) 65.45 (5.6) 57.41 (6.0)
Alcohol problems (APQ scored 1 to 23, 23 most severe) 11.48 (0.6) 11.42 (0.5) 6.37 (0.9) 6.02 (0.7) 6.83 (0.9) 5.29 (0.7)
EQ5D (scored 0–1, 0 worse health utility) 0.62 (0.1) 0.50 (0.1) 0.61 (0.1) 0.68 (0.1) 0.61 (0.1) 0.71 (0.1)
Health-related quality of life (SF12 scored 0–100, 0 most severe)
Mental component 30.61 (1.82) 30.66 (1.93) 37.08 (2.61) 39.15 (2.16) 39.28 (0.06) 40.84 (2.23)
Physical component 42.30 (1.93) 31.50 (1.87) 44.09 (2.07) 44.22 (1.96) 43.93 (1.99) 45.58 (1.99)
Readiness to change, n (%)b
Pre-contemplation 0 0 1 (3.3) 1 (2.9) 1 (4.8) 0
Contemplation 35 (81.4) 37 (75.5) 15 (50) 16 (48.4) 14 (66.7) 21 (77.8)
Action 8 (18.6) 12 (24.5) 14 (46.7) 17 (50.0) 6 (28.6) 6 (22.2)
Severity of dependence (SADQ scored 0–60, 60 most
dependent)
32.38 (2.102) 31.86 (2.043) 18.19 (2.233) 20.41 (2.581) 18.50 (2.273) 15.13 (1.937)
aOne drink = 1 UK unit of alcohol = 8 g ethanol.
bData on Readiness to Change was not obtained from two participants at baseline and 23 at 6 months, and 39 at 12 months. This was because these
Readiness to Change questions were not applicable to participants who were already abstinent at these time points.
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the difference between allocated groups was small and not statistic-
ally signiﬁcant (Table 5).
Secondary outcomes
Signiﬁcant differences were observed between the groups at 6 months
with the ACT plus TAU group having a higher percentage of days
abstinent. At 6 months the TAU group had signiﬁcantly fewer
alcohol-related problems and health utility, measured using the
EQ5D, was signiﬁcantly better for the TAU group at 6 and 12
months. No other signiﬁcant differences between groups on other
secondary outcome measures, including APQ, SF12, Readiness to
Change or SADQ, were found.
Service use
The use of services used in the previous 6 months at 6 and 12 month
follow-up are presented in Table 6. At 6 and 12 months the ACT +
TAU group used signiﬁcantly more alcohol day care services than
the TAU group and signiﬁcantly more alcohol outpatient services at
12 months. At 6 months the ACT + TAU group had signiﬁcantly
fewer inpatient days, outpatient visits to non-alcohol-related services
and signiﬁcantly more GP visits. No signiﬁcant differences were
observed between the groups at 12 months.
Discussion
This study demonstrates the feasibility of recruitment and retention
of participants in a randomized controlled trial of ACT + TAU ver-
sus TAU. Of the 126 patients referred to the research team, 80.3%
provided consent and were randomized. This compares favourably
with previous RCTs in similar clinical populations where eligibility
and consent rates were generally lower (UKATT Research Team,
2005). Further, the follow up rates were higher than in many previ-
ous RCTs with similar alcohol dependent clinical populations. We
achieved a 92.6% follow-up rate at both 6 months and 12 months,
exceeding our minimum target follow up rate of 75% at both follow up
points, and may reﬂect the use of optimal methods to maximize follow-
up (Woolard et al., 2004; Robinson et al., 2007; Zweben et al., 2009).
Table 3. Contact with staff during treatment by allocated group
ACT + TAU (n = 45) TAU (n = 46) Mean difference (80% CI) P-value
Length of contact, mean days (SD) 335.09 (55.87) 95.54 (87.35) 239.55 (219.72; 259.37) 0.000
Number of contacts with participant, mean (SD)
Face to face 22.04 (12.79) 5.09 (4.52) 16.96 (14.34; 19.58) 0.000
Telephone 22.47 (12.14) 3.17 (4.29) 19.29 (16.81; 21.78) 0.000
Group 1.98 (4.59) 1.20 (2.78) 0.78 (−0.25; 1.81) 0.330
Number of contacts with carer, mean (SD)
Face to face 0.16 (0.52) 0 0.16 (0.06; 0.26) 0.051
Telephone 2.50 (4.53) 0.57 (1.38) 1.94 (1.01; 2.86) 0.009
Frequency of contact per week, mean (SD)
All contacts 1.0 (0.41) 1.90 (2.28) −0.89 (−1.34; −0.45) 0.012
All contacts with participant 0.95 (0.39) 1.83 (2.30) −0.88 (−1.33; −0.43) 0.014
Face to face and group contacts 0.48 (0.28) 0.99 (1.71) −0.51 (−0.84; −0.18) 0.051
Place of contact, mean % (SD)
Addictions service 20.67 (15.01) 59.49 (31.95) −38.83 (−45.65; −32.00) 0.000
Home/community 17.84 (17.91) 0.58 (2.67) 17.25 (13.75; 20.76) 0.000
Telephone 54.09 (17.89) 37.49 (32.28) 16.59 (9.54; 23.65) 0.003
Other 7.34 (8.05) 1.86 (7.70) 5.49 (3.35; 7.62) 0.001
Table 4. Mean and mean difference of ACT plus TAU versus TAU in outcomes at 6 months adjusted by baseline covariates
ACT + TAU mean (80% CI) TAU Mean (80% CI) Mean difference (80% CI) P-value
Alcohol use in past 90 days
Mean drinksa consumed 719 (504; 934) 820 (607; 1032) −101 (−404; 202) 0.67
Mean drinks per day 7.95 (5.57; 10.33) 9.15 (6.79; 11.50) −1.97 (−4.55; 2.16) 0.64
Mean percent days abstinent 68.43 (60.63; 76.23) 56.81 (49.09; 64.52) 11.62 (0.64; 22.61) 0.18
Number abstinent (%) 14 (32.6%) 13 (29.5%) – 0.47
Alcohol problems (APQ) 6.37 (5.43; 7.30) 6.03 (5.11; 6.95) 0.34 (−0.97; 1.65) 0.74
EQ5D 0.58 (0.53; 0.64) 0.71 (0.65; 0.76) −0.12 (−0.21; -0.04) 0.05
Health-related quality of life (SF12)
Mental component 36.84 (33.90; 39.77) 38.89 (35.99; 41.78) −2.05 (−6.17; 2.08) 0.52
Physical component 43.73 (41.40; 46.06) 44.33 (42.03; 46.23) −0.60 (−3.87; 2.68) 0.82
Readiness to change n (%)
Pre-contemplation 1 (3.3) 1 (2.9) – 0.96
Contemplation 15 (50.0) 16 (47.1) – 0.37
Action 14 (46.7) 17 (50.0) –
Severity of dependence (SADQ) 17.94 (15.15; 20.74) 20.64 (17.94; 23.34) −2.70 (−6.59; 1.19)
aOne drink = 1 UK unit of alcohol = 8 g ethanol
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The follow up rate was lower in the TAU group compared to the
ACT + TAU group, which may have been related to the more inten-
sive nature of the ACT intervention arm, and potentially a degree of
disappointment in those randomized to TAU (Woolard et al., 2004).
However, the difference in follow up rate was within acceptable lim-
its and greater than the planned minimum follow up rate in both
groups.
In terms of implementation of the ACT intervention, we found
that the clinical teams were able to engage participants for a signiﬁ-
cantly longer period of time than in TAU, and close to the intended
365 days. There was no evidence of contamination between the two
study arms. The ACT group also received a signiﬁcantly greater num-
ber of contacts with specialist staff, and contacts were more often in
participants’ homes or local communities, than in the TAU only
group. Given that there are considerable differences in assertiveness,
intensity and duration of treatment between ACT and treatment typ-
ically delivered by addiction services, this study demonstrates the
feasibility of implementation of ACT in this population.
This pilot study was not designed to be statistically powered to
provide a deﬁnitive test of the effectiveness of ACT + TAU versus
TAU alone. Nevertheless there were some differences in outcome
between the two groups principally at 6 months follow up, with the
ACT + TAU reporting fewer drinking days but lower quality of life
and greater alcohol-related problems than TAU. The ACT + TAU
group also had greater engagement with alcohol services at both
6 and 12 months and signiﬁcantly less unplanned inpatient care and
outpatient hospital visits than the TAU group. The ACT + TAU
group also had signiﬁcantly more GP visits at 6 months. These dif-
ferences may reﬂect improved facilitated access to planned health
interventions supported by the ACT staff and a beneﬁcial reduction
in unplanned care. Overall this pilot RCT demonstrated the feasibil-
ity of conducting a trial of ACT + TAU versus TAU. A deﬁnitive
trial is now warranted.
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Table 6. Mean service utilization (SE) over previous 6 months at 6 and 12 months by allocation
Month 6 Month 12
ACT + TAU TAU P-value ACT+TAU TAU P-value
Alcohol services
Day care 26.5 (4.9) 12.8 (7.2) 0.12 29.0 (6.9) 14.2 (5.3) 0.09
Outpatient 7.2 (1.3) 5.5 (1.2) 0.39 6.9 (2.04) 2.0 (0.7) 0.02
Inpatient nights 33.2 (10.4) 39.2 (10.9) 0.7 61.1 (19.3) 44.1 (13.0) 0.5
Other NHS services
Emergency department 1.3 (0.4) 2.0 (0.9) 0.46 1.1 (0.3) 1.4 (0.5) 0.68
Inpatient nights 1.2 (9.1) 26.8 (6.7) 0.2 1.2 (0.8) 4.2 (3.2) 0.4
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